- Home
- RVPH vs CNOBP Comparison
RVPH vs CNOBP Comparison
Compare RVPH & CNOBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- CNOBP
- Stock Information
- Founded
- RVPH 2006
- CNOBP N/A
- Country
- RVPH United States
- CNOBP United States
- Employees
- RVPH N/A
- CNOBP 493
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- CNOBP Major Banks
- Sector
- RVPH Health Care
- CNOBP Finance
- Exchange
- RVPH Nasdaq
- CNOBP Nasdaq
- Market Cap
- RVPH 32.8M
- CNOBP N/A
- IPO Year
- RVPH N/A
- CNOBP N/A
- Fundamental
- Price
- RVPH $0.40
- CNOBP $23.09
- Analyst Decision
- RVPH Strong Buy
- CNOBP
- Analyst Count
- RVPH 5
- CNOBP 0
- Target Price
- RVPH $9.00
- CNOBP N/A
- AVG Volume (30 Days)
- RVPH 3.4M
- CNOBP N/A
- Earning Date
- RVPH 08-13-2025
- CNOBP N/A
- Dividend Yield
- RVPH N/A
- CNOBP N/A
- EPS Growth
- RVPH N/A
- CNOBP N/A
- EPS
- RVPH N/A
- CNOBP N/A
- Revenue
- RVPH N/A
- CNOBP N/A
- Revenue This Year
- RVPH N/A
- CNOBP N/A
- Revenue Next Year
- RVPH N/A
- CNOBP N/A
- P/E Ratio
- RVPH N/A
- CNOBP N/A
- Revenue Growth
- RVPH N/A
- CNOBP N/A
- 52 Week Low
- RVPH $0.30
- CNOBP N/A
- 52 Week High
- RVPH $4.28
- CNOBP N/A
- Technical
- Relative Strength Index (RSI)
- RVPH 33.44
- CNOBP 57.87
- Support Level
- RVPH $0.35
- CNOBP $22.86
- Resistance Level
- RVPH $0.83
- CNOBP $23.08
- Average True Range (ATR)
- RVPH 0.06
- CNOBP 0.12
- MACD
- RVPH -0.01
- CNOBP 0.00
- Stochastic Oscillator
- RVPH 17.36
- CNOBP 87.76
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental and consumer wages.